Specific immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is double arm: humoral antibody response and T-cell response (9), mainly CD8+ T cells (cytotoxic T lymphocytes [CTL]) (10). Here, CD8A is linked to COVID-19.